123 related articles for article (PubMed ID: 6786322)
1. Calculating the dose of factor VIII in the management of haemophilia.
Ingram GI
Br J Haematol; 1981 Jun; 48(2):351-4. PubMed ID: 6786322
[TBL] [Abstract][Full Text] [Related]
2. Lyophilized cryoprecipitate for children with hemophilia A.
Nuchprayoon I; Sahasittiwat S; Kittikalayawong A; Chantanakajornfung A
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S293-7. PubMed ID: 12188426
[TBL] [Abstract][Full Text] [Related]
3. Management of haemophilia A with antibodies--the effect of combined treatment with factor VIII, hydrocortisone and cyclophosphamide.
Hedner U; Tengborn L
Thromb Haemost; 1985 Dec; 54(4):776-9. PubMed ID: 3937274
[TBL] [Abstract][Full Text] [Related]
4. Dose requirement for replacement therapy in hemophilia A.
Allain JP
Thromb Haemost; 1979 Oct; 42(3):825-31. PubMed ID: 505399
[TBL] [Abstract][Full Text] [Related]
5. Comparison of methods of plasma volume determination for dose calculation of factor VIII in patients with classic haemophilia.
Ockelford PA; Lowe G; Johns AS; Berry EW
N Z Med J; 1986 Feb; 99(796):116-9. PubMed ID: 3081842
[TBL] [Abstract][Full Text] [Related]
6. Hemophilia prophylaxis with factor VIII concentrate.
Kasper CK; Dietrich SL; Rapaport SI
Arch Intern Med; 1970 Jun; 125(6):1004-9. PubMed ID: 4951928
[No Abstract] [Full Text] [Related]
7. Dose and response in haemophilia--optimization of factor replacement therapy.
Srivastava A
Br J Haematol; 2004 Oct; 127(1):12-25. PubMed ID: 15384973
[TBL] [Abstract][Full Text] [Related]
8. [Elimination of inhibitors in children with hemophilia A].
Weissbach G; Domula M; Lenk H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):817-25. PubMed ID: 6083958
[TBL] [Abstract][Full Text] [Related]
9. Optimizing factor prophylaxis for the haemophilia population: where do we stand?
Blanchette VS; Manco-Johnson M; Santagostino E; Ljung R
Haemophilia; 2004 Oct; 10 Suppl 4():97-104. PubMed ID: 15479380
[TBL] [Abstract][Full Text] [Related]
10. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
Kubisz P; Plamenová I; Hollý P; Stasko J
Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
[TBL] [Abstract][Full Text] [Related]
11. Changing pattern of care of boys with haemophilia in western European centres.
Chambost H; Ljung R;
Haemophilia; 2005 Mar; 11(2):92-9. PubMed ID: 15810909
[TBL] [Abstract][Full Text] [Related]
12. Low-dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors.
Unuvar A; Kavakli K; Baytan B; Kazanci E; Sayli T; Oren H; Celkan T; Gursel T
Haemophilia; 2008 Mar; 14(2):315-22. PubMed ID: 18081830
[TBL] [Abstract][Full Text] [Related]
13. Clinical course of factor VIII inhibitors developed after exposure to a pasteurised Dutch concentrate compared to classic inhibitors in hemophilia A.
Mauser-Bunschoten EP; Rosendaal FR; Nieuwenhuis HK; Roosendaal G; Briët E; van den Berg HM
Thromb Haemost; 1994 Jun; 71(6):703-6. PubMed ID: 7974335
[TBL] [Abstract][Full Text] [Related]
14. A comparison of factor VIII infusion methods.
Cox M; Smith J; Miller R; Pasi J
Nurs Times; 1995 Dec 6-12; 91(49):38-9. PubMed ID: 8552500
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two pharmacokinetic techniques for individualizing factor VIII dosage in haemophilia patients.
Morfini M; Grasela TH; Longo G; Matucci M; Messori A; Vannini S; Rossi-Ferrini P
Haematologica; 1985; 70(5):454-6. PubMed ID: 3937784
[No Abstract] [Full Text] [Related]
16. Response of factor VIII/von Willebrand factor to intranasal DDAVP in healthy subjects and mild haemophiliacs (with observations in patients with combined deficiency of factors V and VIII).
Garcia VV; Silva IA; Borrasca AL
Thromb Haemost; 1982 Aug; 48(1):91-3. PubMed ID: 6813999
[TBL] [Abstract][Full Text] [Related]
17. Use of cryoprecipitate antihaemophilic factor for the treatment of haemophilia.
Bloom AL; Emmanuel JH
Q J Med; 1968 Apr; 37(146):291-302. PubMed ID: 5656159
[No Abstract] [Full Text] [Related]
18. Factor VIII half-life and intensity of treatment in hemophilic patients.
Vicente V
Haematologica; 2005 Apr; 90(4):437. PubMed ID: 15820932
[TBL] [Abstract][Full Text] [Related]
19. Comparing prophylaxis with episodic treatment in haemophilia A: implications for clinical practice.
Manco-Johnson M
Haemophilia; 2007 Sep; 13 Suppl 2():4-9. PubMed ID: 17685917
[TBL] [Abstract][Full Text] [Related]
20. Suppression of inhibitors in haemophilia with corticoids and factor VIII.
Aznar JA; Jorquera JI; Peiro A
Thromb Haemost; 1983 Jun; 49(3):248. PubMed ID: 6410535
[No Abstract] [Full Text] [Related]
[Next] [New Search]
